Follow
Edward Nash
Edward Nash
University Hospitals Coventry and Warwickshire NHS Foundation Trust
Verified email at uhcw.nhs.uk
Title
Cited by
Cited by
Year
Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind …
HGM Heijerman, EF McKone, DG Downey, E Van Braeckel, SM Rowe, ...
The Lancet 394 (10212), 1940-1948, 2019
9802019
Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium
JM Bryant, DM Grogono, D Rodriguez-Rincon, I Everall, KP Brown, ...
Science 354 (6313), 751-757, 2016
5232016
The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and healthcare providers
NJ Rowbotham, S Smith, PA Leighton, OC Rayner, K Gathercole, ...
Thorax 73 (4), 388-390, 2018
2342018
Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis
J Tam, EF Nash, F Ratjen, E Tullis, A Stephenson
Cochrane Database of Systematic Reviews, 2013
1652013
Pseudomonas aeruginosa quorum sensing molecules correlate with clinical status in cystic fibrosis
HL Barr, N Halliday, M Cámara, DA Barrett, P Williams, DL Forrester, ...
European Respiratory Journal 46 (4), 1046-1054, 2015
1242015
The global impact of SARS-CoV-2 in 181 people with cystic fibrosis
E McClenaghan, R Cosgriff, K Brownlee, S Ahern, PR Burgel, CA Byrnes, ...
Journal of cystic fibrosis 19 (6), 868-871, 2020
1022020
Analysis of four diverse population groups indicates that a subset of cystic fibrosis mutations occur in common among Caucasians.
GR Cutting, SM Curristin, E Nash, BJ Rosenstein, I Lerer, D Abeliovich, ...
American journal of human genetics 50 (6), 1185, 1992
1001992
Prevalence of dyslipidemia in adults with cystic fibrosis
B Rhodes, EF Nash, E Tullis, PB Pencharz, M Brotherwood, A Dupuis, ...
Journal of Cystic Fibrosis 9 (1), 24-28, 2010
992010
Correlation between genotype and phenotype in patients with cystic fibrosis
A Hamosh, BJ Rosenstein, E Nash, SM Curristin, GR Cutting, M Macek Jr, ...
New England Journal of Medicine, 1993
901993
Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week …
S Sutharsan, EF McKone, DG Downey, J Duckers, G MacGregor, E Tullis, ...
The Lancet Respiratory Medicine 10 (3), 267-277, 2022
762022
Characterising burden of treatment in cystic fibrosis to identify priority areas for clinical trials
G Davies, NJ Rowbotham, S Smith, ZC Elliot, K Gathercole, O Rayner, ...
Journal of Cystic Fibrosis 19 (3), 499-502, 2020
752020
Outcomes of pregnancy in women with cystic fibrosis (CF) taking CFTR modulators–an international survey
EF Nash, PG Middleton, JL Taylor-Cousar
Journal of Cystic Fibrosis 19 (4), 521-526, 2020
692020
Long-term impact of liver transplantation on respiratory function and nutritional status in children and adults with cystic fibrosis
JK Dowman, D Watson, S Loganathan, BK Gunson, J Hodson, DF Mirza, ...
American Journal of Transplantation 12 (4), 954-964, 2012
582012
Incidence of deep vein thrombosis associated with peripherally inserted central catheters in adults with cystic fibrosis
EF Nash, EJ Helm, A Stephenson, E Tullis
Journal of Vascular and Interventional Radiology 20 (3), 347-351, 2009
542009
Chest wall motion analysis in healthy volunteers and adults with cystic fibrosis using a novel Kinect-based motion tracking system
JM Harte, CK Golby, J Acosta, EF Nash, E Kiraci, MA Williams, ...
Medical & biological engineering & computing 54, 1631-1640, 2016
482016
Outcomes of patients with cystic fibrosis undergoing lung transplantation with and without cystic fibrosis‐associated liver cirrhosis
EF Nash, C Volling, CA Gutierrez, E Tullis, A Coonar, K McRae, ...
Clinical transplantation 26 (1), 34-41, 2012
462012
Survival of Burkholderia cepacia sepsis following lung transplantation in recipients with cystic fibrosis
EF Nash, A Coonar, R Kremer, E Tullis, M Hutcheon, LG Singer, ...
Transplant Infectious Disease 12 (6), 551-554, 2010
462010
Employment in adults with cystic fibrosis
K Targett, S Bourke, E Nash, E Murphy, J Ayres, G Devereux
Occupational medicine 64 (2), 87-94, 2014
412014
Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND …
PA Flume, RF Biner, DG Downey, C Brown, M Jain, R Fischer, ...
The Lancet Respiratory Medicine 9 (7), 733-746, 2021
402021
Diagnostic and prognostic significance of systemic alkyl quinolones for P. aeruginosa in cystic fibrosis: a longitudinal study
HL Barr, N Halliday, DA Barrett, P Williams, DL Forrester, D Peckham, ...
Journal of Cystic Fibrosis 16 (2), 230-238, 2017
382017
The system can't perform the operation now. Try again later.
Articles 1–20